This topic contains a solution. Click here to go to the answer

Author Question: Which person is most at risk for a hypersensitivity reaction? a. 26-year-old receiving his second ... (Read 43 times)

javeds

  • Hero Member
  • *****
  • Posts: 570
Which person is most at risk for a hypersensitivity reaction?
 
  a. 26-year-old receiving his second desensitization injection
  b. 35-year-old starting back on birth control tablets
  c. The 52-year-old started on a new series of Pyridium for cystitis
  d. The 84-year-old receiving penicillin for an annually recurring respiratory infection

Question 2

Immediately after the nurse administers an intradermal injection of a suspected antigen during allergy testing, the patient complains of itching at the site, weakness, and dizziness. Which action by the nurse is most appropriate initially?
 
  a. Elevate the arm above the shoulder
  b. Administer subcutaneous epinephrine
  c. Apply a warm compress to area
  d. Apply a local anti-inflammatory cream to the site



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ky860224

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

ANS: D
The 84-year-old with the deteriorated immune system is a prime candidate for a delayed hypersensitivity reaction.

Answer to Question 2

ANS: B
Injection of subcutaneous epinephrine should be given at the first sign of allergy.




javeds

  • Member
  • Posts: 570
Reply 2 on: Jul 11, 2018
Great answer, keep it coming :)


dantucker

  • Member
  • Posts: 346
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library